No results for ‘’
Kopran Ltd
₹203.13
(0.25%)
Wed, 29 Jul 2026, 10:15 am
Health Technology
Pharmaceuticals: Major
24.5KKopran Enterprise Value (EV)
| Particulars | 2004 | 2005 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 0 | 0 | 21.36 | 11.17 | 4.61 | 4.85 | 0 | 18.92 | 16.51 | 11.64 | 7.49 | 5.22 | 7.37 | 20.44 | 19.55 | 24.45 | 21.91 |
| Price to book ratio | 3.05 | 1.65 | 1.05 | 0.45 | 1.63 | 1.28 | 0.77 | 0.58 | 0.79 | 2.08 | 2.12 | 2.63 | 1.65 | 1.07 | 0.58 | 1.85 | 3.19 | 1.21 | 2.54 | 1.63 |
| Price to sales ratio | 1.23 | 0.80 | 0.50 | 0.21 | 0.64 | 0.46 | 0.31 | 0.21 | 0.28 | 0.57 | 0.68 | 1.06 | 0.76 | 0.52 | 0.31 | 0.94 | 2.62 | 0.97 | 2.04 | 1.35 |
| Price to cash flow ratio | 0 | 0 | 8.70 | 44.56 | 0 | 8.32 | 2.37 | 16.21 | 0 | 5.40 | 12.40 | 122.90 | 13.17 | 10.74 | 4.93 | 8.40 | 0 | 17.96 | 35.63 | 25.65 |
| Enterprise value | 405Cr | 378Cr | 215Cr | 147Cr | 218Cr | 193Cr | 164Cr | 159Cr | 216Cr | 263Cr | 278Cr | 417Cr | 319Cr | 269Cr | 193Cr | 513Cr | 1265Cr | 595Cr | 1331Cr | 966Cr |
| Enterprise value to EBITDA ratio | 0 | 0 | 0 | 40.74 | 13.21 | 9.42 | 11.19 | 5.95 | 6.21 | 10.69 | 8.83 | 11.54 | 10.42 | 7.08 | 4.95 | 6.91 | 14.45 | 10.40 | 16.93 | 13.54 |
| Debt to equity ratio | 3.57 | 2.69 | 2.02 | 1.76 | 1.48 | 1.22 | 1.20 | 1.06 | 1.12 | 0.78 | 0.65 | 0.76 | 0.61 | 0.58 | 0.47 | 0.27 | 0.17 | 0.17 | 0.20 | 0.29 |
| Return on equity % | -36.43 | -12.08 | 0 | -20.20 | 0.21 | 5.85 | 6.41 | 12.14 | 16.22 | -36.72 | 10.34 | 17.06 | 14.73 | 15.34 | 11.74 | 28.34 | 18.19 | 6.29 | 10.95 | 7.64 |
Kopran Ltd Enterprise Value
The Kopran Ltd Enterprise Value is a key financial metric used by investors to evaluate Kopran Ltd's valuation, profitability, and overall financial performance. Tracking the Kopran Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Kopran Ltd (NSE: KOPRAN, BSE: 524280) is currently trading at ₹203.13, with a market capitalization of ₹966.2Cr. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Kopran Ltd Enterprise Value is essential for fundamental analysis.
Kopran Ltd Enterprise Value Current Value
The current Kopran Ltd Enterprise Value stands at 966Cr.
The Kopran Ltd Enterprise Value has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Kopran Ltd Enterprise Value Historical Trend
The Kopran Ltd Enterprise Value has shown the following historical trend:
- 2024: 966Cr
- 2023: 1331Cr
- 2022: 595Cr
- 2021: 1265Cr
- 2020: 513Cr
The decline in Kopran Ltd Enterprise Value indicates improving financial efficiency or better earnings growth.
What Kopran Ltd Enterprise Value Indicates for Investors
The Kopran Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Kopran Ltd.
Kopran Ltd Enterprise Value Analysis Summary
The Kopran Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Kopran Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Kopran Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.